Myeloma
Myeloma consultation for diagnosis review, bone marrow evaluation, targeted treatment, chemotherapy, and supportive care planning.
Understanding Myeloma
Myeloma is a blood cancer affecting plasma cells in the bone marrow. It can affect bones, kidneys, blood counts, and immunity.
Treatment depends on symptoms, kidney function, bone involvement, blood counts, and overall fitness.
Bone pain, anemia, kidney problems, or abnormal protein reports need proper evaluation.
Types of Myeloma
Invasive Ductal Carcinoma (IDC)
The most common type — starts in the milk ducts and invades surrounding tissue. Accounts for about 80% of all breast cancer cases.
Invasive Lobular Carcinoma (ILC)
Begins in the lobules (milk-producing glands). Often harder to detect on imaging; requires careful clinical evaluation.
HER2-Positive Breast Cancer
Overexpresses the HER2 protein, making it more aggressive — but highly responsive to targeted therapies like trastuzumab (Herceptin).
Triple-Negative Breast Cancer
Lacks ER, PR, and HER2 receptors. More aggressive and treated primarily with chemotherapy and newer immunotherapy agents.
Hormone Receptor-Positive (HR+)
Fuelled by estrogen or progesterone. Responds well to hormone-blocking therapies such as tamoxifen or aromatase inhibitors.
Inflammatory Breast Cancer
A rare, rapidly progressing form that causes redness and swelling. Requires immediate, aggressive multimodal treatment.
Symptoms to watch for
Recognising early symptoms leads to earlier diagnosis and better outcomes.
How Myeloma is diagnosed
CBC and Kidney Function Tests
Check anemia and kidney status.
Serum Protein Electrophoresis
Detects abnormal protein.
Free Light Chain Assay
Helps diagnose and monitor disease.
Bone Marrow Test
Confirms plasma cell involvement.
PET CT / Skeletal Imaging
Assesses bone disease.
Treatment options available
Treatment depends on type, stage, and patient health. Dr. Kumar designs individualised plans:
Outlook & prognosis
Outcomes depend on stage, subtype, and treatment response. Modern treatments have significantly improved survival:
Controlled Disease
Modern therapy helps control symptoms and disease.
Response Based Care
Treatment is adjusted by response.
Monitoring
Long-term follow-up is required.
Frequently asked questions
Need expert treatment guidance?
Consult Dr. Shikhar Kumar for myeloma evaluation, treatment planning, and blood cancer care guidance.